Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction

Journal of Structural Biology

Volumn 118, Issue 1, 1997, Pages 63-72

  Gobe G ^a   Browning, J ^b   Howard, T ^a   Hogg, N ^a,b   Winterford, C ^a   Cross, R ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN STRUCTURE; ENDOTHELIUM CELL; ENZYME LOCALIZATION; GENE EXPRESSION; HYPERTENSION; IN SITU HYBRIDIZATION; MEMBRANE BINDING; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VASCULAR RESISTANCE;

EID: 0030671499     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1996.3835     Document Type: Article

References (40)

1. Ansari B., Coates P., Greenstein B., Hall P. In situ end labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 170:1993;1-8.
2. Araki S., Shimada Y., Kaji K., Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem. Biophys. Res. Commun. 168:1990;1194-1200.
3. Azmi T. I., O'Shea J. D. Mechanism of deletion of endothelial cells during regression of the corpus luteum. Lab. Invest. 51:1984;206-217.
4. Boegehold M. A., Johnson M., Overbeck H. Pressure-independent arteriolar rarefaction in hypertension. Am. J. Physiol. 261:1991;H83-H87.
5. Boegehold M. A., Kotchen T. A. Arteriolar network morphology in gracilis muscle of rats with salt induced hypertension. Microvasc. Res. 40:1990;169-178.
6. Bohlen G. H. Localization of vascular resistance changes during hypertension. Hypertension. 8:1986;181-183.
7. Bottney M., Bahadori L., Gold L. Vascular remodelling in primary pulmonary hypertension. Potential role for transforming growth factor-β Am. J. Pathol. 144:1994;286-295.
8. Buttke T., Sandstrom P. Oxidative stress as a mediator of apoptosis. Immunol. Today. 15:1994;7-10.
9. Buttyan R., Olsson C., Pintar J., Chang C., Bandyk M., Ng P.-Y., Sawczuk I. Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol. Cell. Biol. 9:1989;3473-3481.
10. Chen I. I., Prewitt R., Dowell R. Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am. J. Physiol. 241:1981;H306-H310.
11. De Lano F., Schmid-Schonbein G., Skalak T., Zweifach B. Penetration of the systemic blood pressure into the microvasculature of rat skeletal muscle. Microvasc. Res. 41:1991;92-110.
12. Detre Z., Jellinek H. Relationship between the early arterial reaction to hypertension and the development of intimal proliferation. Pathol. Res. Pract. 181:1986;60-70.
13. Dvergsten J., Manivel J., Correa-Rotter R., Rosenberg M. Expression of clusterin in human renal diseases. Kidney Int. 45:1994;825-835.
14. Feinberg R. N., Latker C., Beebe D. C. Localized vascular regression during limb morphogenesis in the chicken embryo. I. Spatial and temporal changes in the vascular pattern. Anat. Rec. 214:1986;405-409.
15. Folkow B. Acute effects of pressure on resistance vessel geometry. Clin. Sci. Mol. Med. 55:1978;3S-22S.
16. Folkow B. The structural factor in hypertension, with special emphasis on the hypertrophic adaption of the systemic resistance vessels. Hypertension: Pathophysiology, Diagnosis and Management. 1990;Raven Press, New York. p. 565-581.
17. French L., Wohlwend A., Sappino A.-P., Tschopp J., Schjifferli J. Human clusterin gene expression is confined to surviving cells during in vutro programmed cell death. J. Clin. Invest. 93:1994;877-884.
18. Fritz I., Murphy B. Clusterin. Insights into a multifunctional protein. TEM. 4:1993;41-45.
19. Gobé G. C., Axelsen R. A., Searle J. W. Cellular events in experimental unilateral ischaemic renal atrophy, and in regeneration after contralateral nephrectomy. Lab. Invest. 63:1990;770-779.
20. Gobé G. C., Buttyan R., Wyburn K., Etheridge M. R., Smith P. J. Clusterin expression and apoptosis in tissue remodelling associated with renal regeneration. Kidney Int. 47:1995;411-420.
21. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology. 21:1995;1465-1468.
22. Greene A. S., Tonellato P., Lui J., Lombard J., Cowley A. Microvascular rarefaction and tissue vascular resistance in hypertension. Am. J. Physiol. 256:1989;H126-H131.
23. Hansen-Smith F., Greene A. S., Cowley A. W., Lombard J. H. Structural changes during microvascular rarefaction in chronic hypertension. Hypertension. 15:1990;922-928.
24. Hoffman B., Liebermann D. Molecular controls of apoptosis: Differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene. 9:1994;1807-1812.
25. Kerr J., Winterford C., Harmon B. V. Apoptosis: Its significance in cancer and cancer therapy. Cancer. 73:1994;2013-2026.
26. Kerr J. F. R., Gobé G., Winterford C., Harmon B. Anatomical methods in cell death. Methods Cell Biol. 46:1995;1-27.
27. Korner P., Angus J. Structural determinants of vascular resistance properties in hypertension. J. Vasc. Res. 29:1992;293-312.
28. Lefer A., Ma X. Cytokines and growth factors in endothelial dysfunction. Crit. Care Med. 21:1993;S9-S14.
29. Meredeth J. E., Fazeli B., Schwartz M. A. The extracellular matrix as a mediator of apoptosis. Mol. Biol. Cell. 4:1993;953-961.
30. Polunovsky V., Wendt C., Ingbar D., Peterson M., Bitterman P. Induction of endothelial apoptosis by TNFα: modulation by inhibitors of protein synthesis. Exp. Cell Res. 214:1994;584-594.
31. Prewitt R., Chen I., Dowell R. Microvascular alterations in one-kidney, one-clip renal hypertensive rat. Am. J. Physiol. 246:1984;H728-H732.
32. Robaye B., Mosselmans R., Fiers W., Dumont J., Galand P. Tumour necrosis factor induces apoptosis (programmed cell ceath) in normal endothelial cellsin vitro. Am. J. Pathol. 138:1991;447-453.
33. Struijker Boudier H., Le Noble J., Messing M., Huijberts M., Le Noble F., Van Essen H. The microcirculation and hypertension. J. Hypertens. 10:1992;S147-S156.
34. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
35. Vicault E. Hypertension and the microcirculation: a brief overview of experimental studies. J. Hypertens. 10:1992;S59-S68.
36. Walker N. Ultrastructure of the rat pancreas after experimental duct ligation. Am. J. Pathol. 126:1987;439-451.
37. Walker N. I., Gobé G. C. Cell death and cell proliferation during atrophy of the rat parotid gland induced by duct obstruction. J. Pathol. 153:1987;333-344.
38. Walker N. I., Harmon B. V., Gobé G. C., Kerr J. F. R. Patterns of cell death. Methods Achiev. Exp. Pathol. 13:1988;18-43.
39. Walker N. I., Bennett R., Kerr J. F. R. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat. 185:1989;19-32.
40. Wyllie A. Death from the inside out. Philos. Trans. R. Soc. London. 345:1994;237-241.